Genome Stocks List

Recent Signals

Date Stock Signal Type
2021-02-26 CLLS Crossed Above 200 DMA Bullish
2021-02-26 CLLS Lower Bollinger Band Walk Weakness
2021-02-26 CLLS Doji - Bullish? Reversal
2021-02-26 DTIL Crossed Above 50 DMA Bullish
2021-02-26 DTIL 180 Bullish Setup Bullish Swing Setup
2021-02-26 EDIT Spinning Top Other
2021-02-26 EDIT Lower Bollinger Band Walk Weakness
2021-02-26 ILMN Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-26 ILMN 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-26 ILMN Stochastic Reached Oversold Weakness
2021-02-26 ILMN NR7 Range Contraction
2021-02-26 LOGC 20 DMA Resistance Bearish
2021-02-26 LOGC Calm After Storm Range Contraction
2021-02-26 LOGC 50 DMA Resistance Bearish
2021-02-26 OPGN Spinning Top Other
2021-02-26 OPGN Fell Below 50 DMA Bearish
2021-02-26 QGEN Lower Bollinger Band Walk Weakness
2021-02-26 QGEN 200 DMA Support Bullish
2021-02-26 RPTX Spinning Top Other
2021-02-26 SLN Fell Below 20 DMA Bearish
2021-02-26 SLN Non-ADX 1,2,3,4 Bullish Bullish Swing Setup

Recent News for Genome Stocks

Date Stock Title
Feb 27 EDIT 15 Fastest Growing Biotech Companies in the US
Feb 26 PACB Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conferences
Feb 26 EDIT Truist downgrades shares of Editas Medicine
Feb 26 EDIT Editas (EDIT) Misses on Q4 Earnings, Beats on Revenues
Feb 26 SLN Silence Therapeutics and Mallinckrodt Initiate Work on Third Target as Part of Ongoing RNAi Research Collaboration for Complement-Mediated Diseases
Feb 25 BNGO Bionano’s Saphyr Data Prove Essential in Creating the Most Comprehensive, Ethnically Diverse Collection of Genome Variation Ever Completed
Feb 25 CLLS Cellectis to Hold Fourth Quarter 2020 Earnings Call on Friday, March 5, 2021 at 8:00AM EST
Feb 25 BNGO Analyst Pounds the Table on Bionano (BNGO) Stock
Feb 25 EDIT Editas Medicine downgraded to underweight at JP Morgan on lack of catalysts
Feb 25 EDIT Editas Medicine's (EDIT) CEO Jim Mullen on Q4 2020 Results - Earnings Call Transcript
Feb 25 EDIT Editas Medicine, Inc. (EDIT) Q4 2020 Earnings Call Transcript
Feb 25 EDIT Editas falls again as quarterly loss widens amid revenue slip
Feb 25 EDIT Editas Medicine EPS misses by $0.12, beats on revenue
Feb 25 EDIT Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update
Feb 24 PACB Pacific Biosciences: An Essential Component Of COVID Surveillance
Feb 24 EDIT Editas Medicine Q4 2020 Earnings Preview
Feb 24 QGEN Qiagen to develop a companion diagnostic for Inovio’s VGX-3100 in cervical dysplasia
Feb 24 PACB Children’s Mercy Kansas City Expands Investment in Pacific Biosciences Sequel IIe Systems to Scale Up Whole Genome Research Initiatives Focused on Rare Disease Diagnosis
Feb 24 QGEN The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
Feb 24 QGEN Qiagen, Inovio In Development Pact For VGX-3100 Companion Diagnostics

In the fields of molecular biology and genetics, a genome is all genetic material of an organism. It consists of DNA (or RNA in RNA viruses). The genome includes both the genes (the coding regions) and the noncoding DNA, as well as mitochondrial DNA and chloroplast DNA. The study of the genome is called genomics.

More about Genome
Browse All Tags